ACS Medicinal Chemistry Letters · 2017 · 25 citations · 16 references
MedicineNuclear MedicinePharmacologyBiomedical ImagingBiophysical ChemistryMolecular ImagingAlzheimer DiseaseDementia BiomarkersImaging BiomarkersLigand BindingNeuroimaging In DementiaRadiopharmaceutical DesignAmyloid Beta PeptidesAmyloid Beta PlaquesAmyloid Pet ImagingIn Vivo StudiesMolecular Imaging TracersPet TracersSingle-photon Emission Computed Tomography TracersTransgenic Mice
The development of a 99m Tc-radiotracer for imaging of β-amyloid (Aβ) plaques with single photon emission computed tomography (SPECT) is strongly anticipated to provide a low cost and broadly accessible diagnostic tool for Alzheimer’s disease (AD). Within this framework, 2-(4′-aminophenyl)benzothiazole, known to display affinity and specificity for Aβ plaques, has been joined to the tricarbonyl fac -[M(CO) 3 ] + (M = Re(I), 99m Tc(I)) core through the cyclopentadienyl moiety to yield stable, neutral, and lipophilic complexes ( Re-1 and 99m Tc-1, respectively). The Re-1 complex was completely characterized with spectroscopic methods and was shown to selectively stain Aβ plaques on sections of human AD brain tissue. The 99m Tc-1 complex displayed satisfactory initial brain uptake (0.53% ID/g at 2 min) and in vivo stability in healthy mice, while in transgenic 5xFAD mice, models for AD, a notable retention in the brain was noted (1.94% ID/g at 90 min). The results are encouraging and contribute to the effort of developing a SPECT amyloid imaging agent.
16
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
William E. Klunk, Henry Engler, Agneta Nordberg et al. · Annals of Neurology · 2004 · 4.5K citations
Medicine, Neurology, Neuroscience +15
Holly D. Oakley, Sarah L. Cole, Sreemathi Logan et al. · Journal of Neuroscience · 2006 · 3.6K citations · Full text